Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Sep 27:6:34076.
doi: 10.1038/srep34076.

Systematic meta-analyses and field synopsis of genetic and epigenetic studies in paediatric inflammatory bowel disease

Affiliations

Systematic meta-analyses and field synopsis of genetic and epigenetic studies in paediatric inflammatory bowel disease

Xue Li et al. Sci Rep. .

Abstract

We provide a comprehensive field synopsis of genetic and epigenetic associations for paediatric Inflammatory Bowel Disease (IBD). A systematic review was performed and included 84 genetic association studies reporting data for 183 polymorphisms in 71 genes. Meta-analyses were conducted for 20 SNPs in 10 genes of paediatric Crohn's disease (CD) and for 8 SNPs in 5 genes of paediatric ulcerative colitis (UC). Five epigenetic studies were also included, but formal meta-analysis was not possible. Venice criteria and Bayesian false discovery probability test were applied to assess the credibility of associations. Nine SNPs in 4 genes were considered to have highly credible associations with paediatric CD, of which four variants (rs2066847, rs12521868, rs26313667, rs1800629) were not previously identified in paediatric GWAS. Differential DNA methylation in NOD2 and TNF-α, dysregulated expression in let-7 and miR-124 were associated with paediatric IBD, but not as yet replicated. Highly credible SNPs associated with paediatric IBD have also been implicated in adult IBD, with similar magnitudes of associations. Early onset and distinct phenotypic features of paediatric IBD might be due to distinct epigenetic changes, but these findings need to be replicated. Further progress identifying genetic and epigenetic susceptibility of paediatric IBD will require international collaboration, population diversity and harmonization of protocols.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Flow charts for the selection of eligible genetic and epigenetic studies.

References

    1. Baumgart D. C. & Sandborn W. J. Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet (London, England) 369, 1641–1657, doi: 10.1016/s0140-6736(07)60751-x (2007). - DOI - PubMed
    1. Cosnes J., Gower-Rousseau C., Seksik P. & Cortot A. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology 140, 1785–1794, doi: 10.1053/j.gastro.2011.01.055 (2011). - DOI - PubMed
    1. Griffiths A. M. Growth retardation in early-onset inflammatory bowel disease: should we monitor and treat these patients differently? Digestive diseases (Basel, Switzerland) 27, 404–411, doi: 10.1159/000228581 (2009). - DOI - PubMed
    1. Halme L. et al. Family and twin studies in inflammatory bowel disease. World journal of gastroenterology 12, 3668–3672 (2006). - PMC - PubMed
    1. Orholm M. et al. Familial occurrence of inflammatory bowel disease. The New England journal of medicine 324, 84–88, doi: 10.1056/nejm199101103240203 (1991). - DOI - PubMed

LinkOut - more resources